0000950123-14-006465.txt : 20140521
0000950123-14-006465.hdr.sgml : 20140521
20140520183359
ACCESSION NUMBER: 0000950123-14-006465
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140331
FILED AS OF DATE: 20140521
DATE AS OF CHANGE: 20140520
EFFECTIVENESS DATE: 20140521
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Abingworth LLP
CENTRAL INDEX KEY: 0001397144
IRS NUMBER: 980518585
STATE OF INCORPORATION: X0
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14285
FILM NUMBER: 14859175
BUSINESS ADDRESS:
STREET 1: 38 JERMYN STREET
CITY: LONDON
STATE: X0
ZIP: SW1Y 6DN
BUSINESS PHONE: 44 (0)20 7534 1500
MAIL ADDRESS:
STREET 1: 38 JERMYN STREET
CITY: LONDON
STATE: X0
ZIP: SW1Y 6DN
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001397144
XXXXXXXX
03-31-2014
03-31-2014
Abingworth LLP
38 Jermyn Street
London
X0
SW1Y 6DN
13F HOLDINGS REPORT
028-14285
Abingworth Management LTD
N
John Heard
General Counsel
44 2075341508
John Heard
London
X0
05-20-2014
1
13
181248
false
1
Abingworth Management LTD
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
Amarin
Spons ADR
023111206
14638
8087486
SH
DFND
8087486
0
0
Anthera
Common
03674U102
1467
437994
SH
DFND
437994
0
0
Cempra
Common
15130J109
8243
714285
SH
DFND
714285
0
0
Dicerna
Common
253031108
33314
1182196
SH
DFND
1182196
0
0
GW Pharma (US)
Spons ADR
36197T103
6067
102200
SH
DFND
102200
0
0
Hyperion
Common
44915N101
1612
62500
SH
DFND
62500
0
0
Oncogenex Pharma
Common
68230A106
7088
603740
SH
DFND
603740
0
0
Portola
Common
737010108
32140
1240912
SH
DFND
1
1240912
0
0
Prosensa
Common
N71546100
34860
6213924
SH
DFND
1
6213924
0
0
Regulus
Common
75915K101
2943
327350
SH
DFND
327350
0
0
Supernus
Common
868459108
32148
3600000
SH
DFND
1
3600000
0
0
Zalicus
Common
98887C105
96
78966
SH
DFND
78966
0
0
Zogenix
Common
98978L105
6632
2335218
SH
DFND
1
2335218
0
0